Get started
Lucid_Liquidity

Is SRNE attempting to close the gap?

Long
Lucid_Liquidity  
NASDAQ:SRNE   None
Trend Analysis
5
0
trendanalysis
Certainly does look like it.

If this company can accomplish what they did in the lab and replicate it in their trials with COVID 19 vaccines and treatment cocktails this company will lead the way in the in the treatment of the SARS-COV-2.
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.